1. Scrip
  2. >>Business
  3. >>Strategy

Merck To Spin Out A New Company, Following Industry's Downsizing Trend

 
• By Jessica Merrill

Merck will spinout its mature franchises, including women's health products, into a new company that will have about $6bn-$6.5bn in 2021 revenues and be poised for modest growth.

SC2002_Notebook_385032373_1200.jpg
Merck is spinning out women's health and legacy brands and getting smaller

Big pharma is getting smaller and more focused, not bigger, and now Merck & Co. Inc. is the latest company to announce that it will spin out its more mature pharmaceutical products. Merck announced on 5 February that it will spin off its women's health, legacy brands and biosimilars into a new publicly traded company.

Merck will remain focused on its high-growth drivers: oncology – namely the PD-1 inhibitor Keytruda (pembrolizumab), vaccines, hospital and animal...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Strategy

More from Business

AbbVie Licenses IGI’s ISB 2001 In Second Myeloma Trispecific Deal For 2025

 
• By Alaric DeArment

IGI CEO Cyril Konto said in an interview that his company picked AbbVie for its agility, drug development acumen and expertise in areas like intellectual property and legal affairs.

Merck & Co. Remains In The BD Game After Verona Takeout

 
• By Jessica Merrill

CEO Rob Davis said the company is in pursuit of more deals as it looks to close the revenue gap looming from the loss of Keytruda in 2028.

Asia Deal Watch: JXR And Alexion Build Upon Existing Gene Therapy Alliances

 
• By Joseph Haas, Lisa Takagi, Sushmita Panda, and Anju Ghangurde

Plus deals involving TandemAI/Perpetual Medicines, Biocytogen/BeOne, Chugai/Gero, CStone/Istituto Gentili, Alembic/Utility, Brii/Joincare, HanchorBio/Henlius, Rakuten/Cyntec and more.